SCHEMBL8020148

SCHEMBL8020148

COc1ccc(-c2cc(Oc3cc(C(=N)N)ccc3O)nc(Oc3cccc(C4=NCCN4C)c3)n2)cc1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.69
F2 P00734 17/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652423 0.94 F10 (0.71) F10F2
SCHEMBL7659287 0.94 F10 (0.73) F10F2
SCHEMBL7658893 0.94 F10 (0.71) F10F2
SCHEMBL7379477 0.94 F10 (0.75) F10F2
SCHEMBL7660545 0.93 F10 (0.70) F10F2
SCHEMBL7660167 0.92 F10 (0.74) F10F2
SCHEMBL7660200 0.92 F10 (0.68) F10F2
SCHEMBL7373449 0.91 F10 (0.75) F10F2
SCHEMBL7658330 0.89 F10 (0.69) F10F2
SCHEMBL7375196 0.89 F10 (0.75) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127376-A A BLOOD FACTOR XA ENZYME INHIBITOR TREATING A HUMAN HAVING A DISEASE-STATE CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. (US) 2000-10-03 US disclosed